G566-0363 Screening compound: N-{2-[({2-methyl-7-oxo-7H-[1,2]oxazolo[2,3-a]pyrimidin-5-yl}methyl)sulfanyl]-1,3-benzothiazol-6-yl}-2,2-diphenylacetamide

G566-0363 Screening compound: N-{2-[({2-methyl-7-oxo-7H-[1,2]oxazolo[2,3-a]pyrimidin-5-yl}methyl)sulfanyl]-1,3-benzothiazol-6-yl}-2,2-diphenylacetamide
G566-0363 Screening compound: N-{2-[({2-methyl-7-oxo-7H-[1,2]oxazolo[2,3-a]pyrimidin-5-yl}methyl)sulfanyl]-1,3-benzothiazol-6-yl}-2,2-diphenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G566-0363
N-{2-[({2-methyl-7-oxo-7H-[1,2]oxazolo[2,3-a]pyrimidin-5-yl}methyl)sulfanyl]-1,3-benzothiazol-6-yl}-2,2-diphenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G566-0363

Molecular Formula

C29H22N4O3S2 (C29 H22 N4 O3 S2)

Compound Name

N-{2-[({2-methyl-7-oxo-7H-[1,2]oxazolo[2,3-a]pyrimidin-5-yl}methyl)sulfanyl]-1,3-benzothiazol-6-yl}-2,2-diphenylacetamide

IUPAC name

N-{2-[({2-methyl-7-oxo-7H-[12]oxazolo[23-a]pyrimidin-5-yl}methyl)sulfanyl]-13-benzothiazol-6-yl}-22-diphenylacetamide

SMILES

CC(ON12)=CC2=NC(CSc2nc(ccc(NC(C(c3ccccc3)c3ccccc3)=O)c3)c3s2)=CC1=O

InChI

InChI=1S/C29H22N4O3S2/c1-18-14-25-30-22(16-26(34)33(25)36-18)17-37-29-32-23-13-12-21(15-24(23)38-29)31-28(35)27(19-8-4-2-5-9-19)20-10-6-3-7-11-20/h2-16,27H,17H2,1H3,(H,31,35)

InChI Key

VQQVLMHSNCQAKH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15019973

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

538.65

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.374

Distribution Coefficient, logD

5.373

Water Solubility, LogSw

-5.41

Polar Surface Area

70.332

Acid Dissociation Constant (pKa)

10.27

Base Dissociation Constant (pKb)

-2.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.30

G566-0363 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G566-0363 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G566-0363?
Check Price and Availability of G566-0363, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G566-0363 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G566-0363
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G566-0363
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G566-0363 available by request